-
Key Takeaways of Trials in Metastatic CRC Explored
07 Jul 2025 23:30 GMT
… in the Department of Medical Oncology & Therapeutics Research … treatment in metastatic colorectal cancer (CRC).
The combination of bevacizumab (Avastin …
Additionally, the FRESCO-2 trial (NCT04322539) has shown OS … and the FRESCO-2 [trials].
1:34 | There …
-
Real-World Analysis Reveals Shorter Survival in KRAS G12C–Mutant Metastatic CRC After First-Line Treatment
07 Jul 2025 21:05 GMT
… patient demographics, clinicopathologic characteristics and treatment patterns, and survival outcomes in … ) with or without bevacizumab (Avastin) had a median OS of … GSK, Janssen, Merck, Pfizer, Revolution Medicine, Taiho, and Takeda; financial interests …
-
Biomarker-Directed Therapies Improve Outlooks for the mCRC Treatment Arsenal: With Chandler Park, MD; and Midhun Malla, MD
03 Jul 2025 03:01 GMT
… Park, MD, a medical oncologist at Norton Cancer … areas, in accessing clinical trials, which remain a … in the absence of trial availability or when patients … Avastin); fruquintinib (Fruzaqla); and regorafenib (Stivarga). These agents offer viable treatment …
-
STF busts ₹1.20 cr cancer-drug smuggling racket in Lucknow, three held
03 Jul 2025 00:20 GMT
… urged citizens to procure critical medicines only from licensed pharmacies to … STF, the gang was smuggling Avastin injections illegally sourced from Bihar … nearby districts. The drugs, typically used for cancer treatment and requiring strict …
-
New ASTRO Guidelines Highlight RT in WHO Grade 4 Adult-Type Diffuse Glioma
06 Jul 2025 16:42 GMT
… patient enrollment in clinical trials or multi-institutional registries … receiving reirradiation with concomitant bevacizumab (Avastin) to reduce toxicity, the … in personalized medicine, biomarker discovery, and advanced treatment techniques could help …
-
Dr Olawaiye on Phase 2 Data With Relacorilant and Nab-Paclitaxel in Ovarian Cancer
08 Jul 2025 02:42 GMT
… the University of Pittsburgh Medical Center, discussed prior data … of thephase 3 ROSELLA trial (NCT05257408).
Relacorilant is …
ROSELLA was the confirmatory trial of relacorilant plus nab … of therapy—including bevacizumab (Avastin), and have experienced disease …
-
MAIC Analysis Suggests PFS, OS Advantage With Nivolumab/Ipilimumab Over Other First-Line IO Regimens in HCC
07 Jul 2025 21:05 GMT
… (Tecentriq) plus bevacizumab (Avastin) overall and after 6 months … trial (NCT04039607).
In the absence of head-to-head trials … a study utilizing indirect treatment comparisons (ITCs).
Prior … GE Healthcare, and Otsuka Pharmaceutical.
Reference
Kudo M, Galle …
-
PAOLA-1 Analysis Shows PD-L1 Expression Correlates With HRD Positivity in High-Grade Serous Ovarian Cancer
07 Jul 2025 21:05 GMT
… 1/ENGOT-ov25 trial (NCT02477644), PD-L1 … and bevacizumab (Avastin) for first-line maintenance treatment of adult patients … fda.gov/drugs/;resources-information-approved-drugs/fda-approves-olaparib-plus-bevacizumab-maintenance-treatment …
-
Dr Finn on Adding Tiragolumab to Atezolizumab and Bevacizumab in Locally Advanced or Metastatic HCC
05 Jul 2025 13:20 GMT
… School of Medicine in the Department of Medicine, Division … (Tecentriq) and bevacizumab (Avastin) in patients with unresectable … ongoing randomized, placebo-controlled trial assessing the triplet of … . Given the evolving treatment landscape—highlighted by the …
-
Real-World Analysis Sheds Light on Fruquintinib Use in Later-Line Metastatic CRC
04 Jul 2025 23:29 GMT
… Lonsurf] and bevacizumab [Avastin] followed by fruquintinib,” Verdasca … the FDA approved fruquintinib for the treatment of adult … RAS wild-type and medically appropriate, an anti … www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- …
About
© 1995-2025